Clinical trial Recruiting at 1 site Interventional Ages 18 to 70

AI-assisted approach to diagnose and treat temporomandibular disorders

Official title: Development of an Integrated Evaluation-to-Treatment Framework to Enhance Clinical Efficiency and Effectiveness in Temporomandibular Disorders

Run by En Chu Kong Hospital · NCT07771296 · Data updated 2026-11-12

This study tests a machine-learning approach that uses clinical data, CBCT, and MRI to guide personalized treatment for people with temporomandibular disorders.

More Temporomandibular Disorders (TMD) trials

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment180 (estimated)
SponsorEn Chu Kong Hospital
Academic / other
Locations1 site (New Taipei City, Sanxia)
StatusRecruiting
StartedOctober 9, 2026
Main results expectedJuly 25, 2027
Study endsJuly 31, 2027
Registry record updatedOctober 13, 2026
Trial IDNCT07771296 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18-70 with TMD-related muscle-origin jaw pain who have not fully responded to analgesics for at least one week and meet baseline eligibility.

Probably not a fit

Patients with significant psychosocial comorbidity, TMJ/head and neck tumors, active infections, or certain exclusions may not benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The trial combines machine learning with standard clinical assessment and imaging to identify core issues in TMD patients. It enrolls about 180 participants and uses strict screening to exclude psychosocial confounders and certain comorbidities. Baseline CBCT and MRI data, along with clinical exams, train multi-modal models to predict the need for MRI and to tailor treatment. Participants are stratified by maximum mouth opening and randomized to three treatment arms: proprioceptive training with sham laser and low-level laser therapy (LLLT), proprioceptive training with active LLLT, or a waiting-list control receiving standard care. The aim is to improve diagnostic precision and create a predictive framework for imaging necessity and targeted interventions.

Why it matters

Potential benefit: If successful, patients may receive more precise diagnoses and more effective, customized treatment plans with potentially fewer unnecessary MRI scans.

How similar studies have gone: Prior studies have shown promise for multi-modal imaging and machine-learning insights in musculoskeletal disorders, though this exact approach in TMD is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients diagnosed with temporomandibular disorders (TMDs) screened by the Department of Dentistry, Division of Oral and Maxillofacial Surgery at En Chu Kong Hospital, who have failed to respond to analgesic treatment for at least one week.
* Patients clinically examined and identified as having pain predominantly originating from muscles associated with mandibular movement.
* Patients aged between 18 and 70 years (inclusive) with full legal capacity.
* Patients who are willing to participate in the study and provide written informed consent.

Exclusion Criteria:

* Patients meeting any of the following clinical scale thresholds: Generalized Anxiety Disorder-7 (GAD-7)≥ 10, Patient Health Questionnaire-9 (PHQ-9) ≥ 15, Patient Health Questionnaire-15 (PHQ-15) ≥ 10, or Pittsburgh Sleep Quality Index (PSQI) \> 5.
* Patients with tumors of the temporomandibular joint (TMJ) or head and neck region.
* Patients with acute or chronic infections.
* Patients with a history of neuropathy or stroke.
* Patients with a history of head and neck trauma.
* Patients diagnosed with fibromyalgia.
* Patients diagnosed with autoimmune or rheumatic diseases.
* Patients diagnosed with irritable bowel syndrome (IBS).
* Patients with claustrophobia (unable to undergo MRI examination).
* Women who are pregnant or lactating, or parents currently in the infant care/nursing period.
* Patients who have received invasive treatment for temporomandibular joint disorders within the past 3 months.

Where it's running

  • En Chu Kong Hospital
    New Taipei City, Sanxia, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.